Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $1.23 Million - $1.45 Million
2,349 Added 62.66%
6,098 $3.55 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $644,225 - $888,162
1,482 Added 65.37%
3,749 $2.01 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $795,127 - $1.06 Million
2,267 New
2,267 $1.06 Million
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $1.28 Million - $1.58 Million
-11,935 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $1.27 Million - $1.39 Million
11,935 New
11,935 $1.34 Million
Q2 2019

Aug 14, 2019

SELL
$110.79 - $129.32 $5.13 Million - $5.98 Million
-46,268 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$111.31 - $131.02 $3.93 Million - $4.63 Million
35,329 Added 322.96%
46,268 $6 Million
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $115,960 - $129,910
1,095 Added 11.12%
10,939 $1.27 Million
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $40,525 - $50,650
472 Added 5.04%
9,844 $1.06 Million
Q2 2018

Aug 14, 2018

BUY
$75.7 - $86.88 $709,460 - $814,239
9,372 New
9,372 $800,000
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $18 Million - $21.3 Million
-243,108 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $19.9 Million - $21.4 Million
243,108
243,108 $20.5 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $750B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Blue Crest Capital Management LTD Portfolio

Follow Blue Crest Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Blue Crest Capital Management LTD with notifications on news.